Adaptive Biotechnologies Corporation (ADPT) Q1 2020 Earnings Results

Adaptive Biotechnologies Misses on EPS — Stock Down 0.16%

This earnings report indicates that Adaptive Biotechnologies is facing challenges, as evidenced by the missed EPS target. The stock's slight decline of 0.16% suggests that investors may be cautious following the results. The lack of revenue data and forward guidance adds to the uncertainty surrounding the company's future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.25	N/A	-15.21%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed concern about the ongoing market conditions affecting performance. They did not provide any forward-looking guidance.

Management did not provide specific guidance for future quarters.

The company acknowledged challenges in the current market environment.

Adaptive Biotechnologies Misses on EPS — Stock Down 0.16%

Key numbers

Management commentary

Adaptive Biotechnologies Corporation

More earnings this week

Adaptive Biotechnologies Misses on EPS — Stock Down 0.16%

Key numbers

Management commentary